Daniel Schwartzlose

Investitore di Private Equity presso

NC Advisory A/S

Consumer Services

Health Technology

Finance

Profilo

Daniel Schwartzlose is currently Managing Director at NC Advisory A since 2022.
Mr. Schwartzlose was President & Xellia International at Xellia Pharmaceuticals AS from 2019 to 2022 and worked at Xellia Pharmaceuticals AS from 2014 to 2022.
Mr. Schwartzlose earned an MBA from the University of Technology Sydney in 2002 and graduated from the University of Copenhagen in 2003.

Posizioni attive di Daniel Schwartzlose

Società	Posizione	Inizio
NC Advisory A/S NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager	Investitore di Private Equity	01/01/2022

Tutte le posizioni attive di Daniel Schwartzlose

Precedenti posizioni note di Daniel Schwartzlose

Società	Posizione	Fine
Xellia Pharmaceuticals AS Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs	Investitore di Private Equity	01/01/2022

Vedi nel dettaglio l'esperienza di Daniel Schwartzlose

Formazione di Daniel Schwartzlose

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Daniel Schwartzlose

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
University of Technology Sydney University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xellia Pharmaceuticals AS Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs	Health Technology
NC Advisory A/S NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager	Finance